Sertraline Hepatotoxicity: Report of a Case and Review of the Literature
The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, numerous clinical adverse events involving liver toxicity have been reported during sertraline therapy, two of which caused severe hepatitis (Collados et al., 2010; Collados Arroyo et al., 2008; Fartoux-Heymann et al., 2001; Hautekeete et al., 1998; Kim et al., 1999; Martínez Matos, 2002; Persky and Reinus, 2003; Verrico et al., 2000).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Collados et al., 2010
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Lammert, C., Einarsson, S., Saha, C., Niklasson, A., Bjornsson, E., & Chalasani, N. (2008) · Hepatology · doi:10.1002/hep.22272 · Cited by 389
Zimmerman, H. J. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70097-0 · Cited by 186
Hepatotoxicity Associated With the New Antidepressants
Garcia-Pando, A. C., del Pozo, J. G., Sanchez, A., Martin, A. V., de Castro, A. M. R., & Lucena, M. I. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0208 · Cited by 109
Antidepressant-induced hepatotoxicity
Lucena, M. I., Carvajal, A., Andrade, R. J., & Velasco, A. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.3.249 · Cited by 78
Self-citationPersky, S. E., & Reinus, J. F. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1023007831047 · Cited by 41
Fulminant Chemical Hepatitis Possibly Associated with Donepezil and Sertraline Therapy
Verrico, M. M., Nace, D. A., & Towers, A. L. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03879.x · Cited by 38
Symptomatic liver injury probably related to sertraline.
Hautekèete, M., Colle, I. O., Vlierberghe, H. V., & Elewaut, A. (1998) · PubMed · Cited by 34
Acute fatal hepatitis related to sertraline
Fartoux-Heymann, L., Hézode, C., Zafrani, E. S., Dhumeaux, D., & Mallat, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00159-3 · Cited by 32
Research works printed but not linked: 2
- Tabak T, Gunduz F, Tahan V, Tabak O, Ozaras R. Sertraline Hepatotoxicity: Report of a Case and Review of the Literature.
- Galán Navarro JL. Hepatitis aguda colestásica probablemente causada por sertralina. Rev Esp Enferm Dig. 2001;93(12):822.
Cited by
Antidepressant-Induced Liver Injury: A Review for Clinicians
Voican, C. S., Corruble, E., Naveau, S., & Perlemuter, G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13050709 · Cited by 275
Nicoletti, P., Aithal, G. P., Bjornsson, E. S., Andrade, R. J., Sawle, A., Arrese, M., Barnhart, H. X., Bondon-Guitton, E., Hayashi, P. H., Bessone, F., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.016 · Cited by 221
Self-citationPsychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity
Telles‐Correia, D., Barbosa, A., Cortez‐Pinto, H., Campos, C., Rocha, N. B. F., & Machado, S. E. D. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i1.26 · Cited by 145
Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent
Li, Y., Couch, L., Higuchi, M., Fang, J.-L., & Guo, L. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs100 · Cited by 120
Antidepressants- and antipsychotics-induced hepatotoxicity
Todorović Vukotić, N., Đorđević, J., Pejić, S., Đorđević, N., & Pajović, S. B. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02963-4 · Cited by 114
PharmGKB summary: sertraline pathway, pharmacokinetics
Huddart, R., Hicks, J. K., Ramsey, L. B., Strawn, J. R., Smith, D. M., Babilonia, M. B., Altman, R. B., & Klein, T. E. (2019) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000392 · Cited by 94
Chen, S., Xuan, J., Wan, L., Lin, H., Couch, L., Mei, N., Dobrovolsky, V. N., & Guo, L. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kft254 · Cited by 75
“Acute liver failure due to sertraline use has been described, although the frequency is relatively low (Carvajal Garcia-Pando et al., 2002; Collados et al., 2010; FartouxHeymann et al., 2001; Galan Navarro, 2001; Hautekeete et al., 1998; Kim et al., 1999; Persky and Reinus, 2003; Tabak et al.,…”
BackgroundSertraline induces endoplasmic reticulum stress in hepatic cells
Chen, S., Xuan, J., Couch, L. H., Iyer, A., Wu, Y., Li, Q., & Guo, L. (2014) · Toxicology · doi:10.1016/j.tox.2014.05.007 · Cited by 71
Sertraline as an Additional Treatment for Cholestatic Pruritus in Children
Thébaut, A., Habès, D., Gottrand, F., Rivet, C., Cohen, J., Debray, D., Jacquemin, E., & Gonzales, E. M. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001385 · Cited by 68
“None of these events was life threatening and no liver toxicity, as previously reported in some patients (18) and in experimental models (19), was observed in this population of children with a chronic liver disease.”
Endoplasmic Reticulum Stress in Drug- and Environmental Toxicant-Induced Liver Toxicity
Chen, S., Melchior, W. B., & Guo, L. (2014) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2014.881648 · Cited by 63
A Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder
Dodd, S., Malhi, G. S., Tiller, J., Schweitzer, I., Hickie, I., Khoo, J. P., Bassett, D. L., Lyndon, B., Mitchell, P. B., Parker, G., et al. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.595686 · Cited by 45
The role of hepatic cytochrome P450s in the cytotoxicity of sertraline
Chen, S., Wu, Q., Li, X., Li, D., Fan, M., Ren, Z., Bryant, M., Mei, N., Ning, B., & Guo, L. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02753-y · Cited by 35
“Clinically, multiple adverse hepatic events, including severe hepatitis, have been reported during sertraline therapy (Collados Arroyo et al. 2008; Collados et al. 2010; Fartoux-Heymann et al. 2001; Galan Navarro 2001; Hautekeete et al. 1998; Kim et al. 1999; Persky and Reinus 2003; Verrico et al. 2000).”
BackgroundSSRIs as Moral Enhancement Interventions: A Practical Dead End
Wiseman, H. (2014) · AJOB Neuroscience · doi:10.1080/21507740.2014.911214 · Cited by 38
“…[Marks et al. 2008, 783]; there is also potential for SSRIs to interfere with other medications that might later be required; the “impairment of primary haemostasis”15 [De Abajo 2011, 345]; and (albeit rarely) the possibility of serious liver damage [(hepatotoxicity); Tabak et al. 2009, 1589]).”
BackgroundWhich psychotropic medications induce hepatotoxicity?
Sedky, K., Nazir, R., Joshi, A., Kaur, G., & Lippmann, S. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.10.007 · Cited by 32
“Seven documented cases of severe toxicity are associated with this agent [13].”
BackgroundHepatotoxicity of Psychotropic Drugs and Drugs of Abuse
Larrey, D. G., & Ripault, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00025-x · Cited by 34
In vivo investigation on the chronic hepatotoxicity induced by sertraline
Almansour, M. I., Jarrar, Y. B., & Jarrar, B. M. (2018) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2018.05.021 · Cited by 30
Acute liver injury secondary to sertraline
Suen, C. L. W., Boyapati, R. K., Simpson, I. J., & Dev, A. T. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-201022 · Cited by 23
Ataei, S., Kord, L., Harchegani, A. L., Yasrebifar, F., Mehrpooya, M., Seyedtabib, M., & Hasanzarrini, M. (2019) · Reviews on Recent Clinical Trials · doi:10.2174/1574887114666190328130720 · Cited by 22
Antidepressant-Induced Acute Liver Injury: A Case–Control Study in an Italian Inpatient Population
on behalf of DILI-IT Study Group, Ferrajolo, C., Scavone, C., Donati, M., Bortolami, O., Stoppa, G., Motola, D., Vannacci, A., Mugelli, A., Leone, R., et al. (2017) · Drug Safety · doi:10.1007/s40264-017-0583-5 · Cited by 19
“Moreover, in all cases both ALT and AST elevation as well as administration of concomitant drugs were confirmed [4, 33].”
BackgroundSertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome
Conrad, M. A., Cui, J., & Lin, H. C. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.10.065 · Cited by 19
Roles of X-box binding protein 1 in liver pathogenesis
Tak, J., Kim, Y. S., & Kim, S. G. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0441 · Cited by 20
Sertraline Induces Toxicity and Behavioral Alterations in Planarians
Thumé, I. S., & Frizzo, M. E. (2017) · BioMed Research International · doi:10.1155/2017/5792621 · Cited by 15
Pytka, K., Głuch‐Lutwin, M., Knutelska, J., Jakubczyk, M., Waszkielewicz, A. M., & Kotańska, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165495 · Cited by 9
Sertraline reduces glutamate uptake in human platelets
Rodrigues, D. O., Bristot, I. J., Klamt, F., & Frizzo, M. E. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.10.014 · Cited by 9
Osorio, S., Escudero‐Vilaplana, V., Reguilón‐Gallego, L., Gómez-Centurión, I. A., Díez, J. L., & Ferrer‐Marín, F. (2017) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155217735689 · Cited by 8
Hwang, J. T., Kim, S., Choi, I., & Choi, S. Y. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.711841 · Cited by 7
“…since the adverse effects of commonly used anti-obesity drugs, such as orlistat, sibutramine and sertraline, have been reported (Ghanizadeh, 2008; Tabak et al., 2009; García & Martín, 2011), studies involving the research and development of anti-obesity substances that can replace the above…”
BackgroundRenemane, L., & Rancāns, E. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1456455 · Cited by 9
Abelaira, H. M., de Moura, A. B., Cardoso, M. M., Pieri, E. D., Abel, J. S., Luiz, G. P., Sombrio, E. M., Borghezan, L. A., Anastacio, R. S., Cruz, L. A. X., et al. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173661 · Cited by 7
Siwek, M., Krupa, A. J., & Woroń, J. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2352468 · Cited by 4
“Similarly to us, Damsa et al. provided a review on the dopa-mine-dependent adverse effects (including gynecomastia) due to selective serotonin reuptake inhibitors [115], while several other authors described cases and studies of hepatotoxicity due to sertraline [116–118].”
ResultSertraline Induced Hepatotoxicity: A Case Report and Review of Literature
(2011) · The Internet Journal of Gastroenterology · doi:10.5580/1602 · Cited by 3
“Although exceedingly rare, hepatotoxicity resulting from Sertraline use has been previously reported (3-7).”
BackgroundSertraline Induced Acute Hepatitis: A Case Report
Abdullah, A. A., Ibrahim, A. S., & Ahmed, H. F. (2015) · Health · doi:10.4236/health.2015.74056 · Cited by 2
“However, the time to normalization of liver function is variable and has been reported at 6 months following cessation of the drug [17].”
BackgroundMitchell, P. B. (2011) · Side effects of drugs annual · doi:10.1016/b978-0-444-53741-6.00002-7 · Cited by 1
Drug and Toxin-Induced Liver Injury
Kanel, G. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82533-7.00006-5 · Cited by 2
Metadata
- Authors
- Collados, V., Hallal, H., & Andrade, R. J.
- Affiliations
- Hospital General Universitario Morales Meseguer (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Venue
- Digestive Diseases and Sciences
- Published
- 2010-04-22
- Volume
- 55
- Issue
- 6
- Pages
- 1806-1807
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2153915394
- Cited by
- 33
- References
- 15
- Citations by year
- 2024: 3 · 2023: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 2
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- sertraline, drug-induced liver injury, selective serotonin reuptake inhibitors, alanine aminotransferase, aspartate aminotransferase, adverse drug reactions, antipsychotic adverse effects
- MeSH terms
- Antidepressive Agents, Humans, Medical Records, Review Literature as Topic, Time Factors, Selective Serotonin Reuptake Inhibitors, Sertraline, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.